Treatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRadiotherapyChemotherapy, AdjuvantRadiotherapy DosageCombined Modality TherapyRadiotherapy, AdjuvantRadiotherapy, ConformalCisplatinAntineoplastic AgentsCyclophosphamideDoxorubicinRadiotherapy, Intensity-ModulatedDisease-Free SurvivalNeoplasm StagingRadiotherapy, High-EnergyNeoadjuvant TherapyRadiotherapy Planning, Computer-AssistedSurvival AnalysisBreast NeoplasmsSurvival RateLung NeoplasmsPrognosisNeoplasm Recurrence, LocalEtoposideDose FractionationRadiation InjuriesDrug Administration ScheduleMethotrexateCarboplatinVinblastineFollow-Up StudiesRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedNeoplasmsPaclitaxelInduction ChemotherapyBleomycinBrain NeoplasmsHead and Neck NeoplasmsChemoradiotherapyTaxoidsIfosfamideCarcinoma, Non-Small-Cell LungHodgkin DiseaseCarcinoma, Squamous CellAntineoplastic Agents, AlkylatingDeoxycytidineSalvage TherapyAntimetabolites, AntineoplasticAdenocarcinomaDrug Resistance, NeoplasmDacarbazineTime FactorsOrganoplatinum CompoundsNeoplasm MetastasisRadiation OncologyNasopharyngeal NeoplasmsTesticular NeoplasmsCranial IrradiationKaplan-Meier EstimateDose-Response Relationship, RadiationLymphoma, Non-HodgkinProspective StudiesAnthracyclinesCytarabineBrachytherapyLomustineChemotherapy, Cancer, Regional PerfusionPalliative CareRectal NeoplasmsBone NeoplasmsLymphatic MetastasisAntineoplastic Agents, PhytogenicOvarian NeoplasmsRadiosurgeryClinical Trials as TopicCarcinomaNeutropeniaTransplantation, AutologousVomitingNauseaNeoplasms, Second PrimaryColorectal NeoplasmsTomography, X-Ray ComputedCarmustineLeukopeniaTumor Markers, BiologicalRecurrenceAntibiotics, AntineoplasticMitomycinNeoplasms, Germ Cell and EmbryonalSarcomaLiver NeoplasmsCamptothecinCell Line, TumorRadiation ToleranceRadiation-Sensitizing AgentsVindesineOsteosarcoma